Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Bryan Daehahn Choi, M.D.,Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Choi BD, Grannan BL, Cahill DP, Curry WT. Commentary: The Glioma-Network Interface: A Review of the Relationship Between Glioma Molecular Subtype and Intratumoral Function. Neurosurgery. 2021 Feb 16; 88(3):E273-E274. PMID: 33370805.
    Citations:    Fields:    
  2. Simon MV, Lee DK, Choi BD, Talati PA, Yang JC, Koch MJ, Jones PS, Curry WT. Neurophysiologic Mapping of Thalamocortical Tract in Asleep Craniotomies: Promising Results From an Early Experience. Oper Neurosurg (Hagerstown). 2021 Jan 13; 20(2):219-225. PMID: 33269396.
    Citations:    Fields:    
  3. Starkweather CK, Choi BD, Alvarez-Breckenridge C, Brastianos PK, Oh K, Wang N, Shih H, Nahed BV. Initial Approach to the Patient with Multiple Newly Diagnosed Brain Metastases. Neurosurg Clin N Am. 2020 Oct; 31(4):505-513. PMID: 32921347.
    Citations:    Fields:    
  4. Gedeon PC, Champion CD, Rhodin KE, Woroniecka K, Kemeny HR, Bramall AN, Bernstock JD, Choi BD, Sampson JH. Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook. Expert Rev Clin Pharmacol. 2020 Oct; 13(10):1147-1158. PMID: 32862726.
    Citations:    Fields:    Translation:HumansAnimals
  5. Schmidts A, Marsh LC, Srivastava AA, Bouffard AA, Boroughs AC, Scarfò I, Larson RC, Bedoya F, Choi BD, Frigault MJ, Bailey SR, Leick MB, Vatsa S, Kann MC, Prew MS, Kleinstiver BP, Joung JK, Maus MV. Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources. J Immunother Cancer. 2020 09; 8(2). PMID: 32900862.
    Citations: 1     Fields:    
  6. Richardson LG, Nieman LT, Stemmer-Rachamimov AO, Zheng XS, Stafford K, Nagashima H, Miller JJ, Kiyokawa J, Ting DT, Wakimoto H, Cahill DP, Choi BD, Curry WT. IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice. Oncoimmunology. 2020 08 20; 9(1):1806662. PMID: 32923170.
  7. McAvoy MB, Choi BD, Jones PS. Immune Therapy for Central Nervous System Metastasis. Neurosurg Clin N Am. 2020 Oct; 31(4):627-639. PMID: 32921357.
    Citations:    Fields:    
  8. Boroughs AC, Larson RC, Marjanovic ND, Gosik K, Castano AP, Porter CBM, Lorrey SJ, Ashenberg O, Jerby L, Hofree M, Smith-Rosario G, Morris R, Gould J, Riley LS, Berger TR, Riesenfeld SJ, Rozenblatt-Rosen O, Choi BD, Regev A, Maus MV. A Distinct Transcriptional Program in Human CAR T Cells Bearing the 4-1BB Signaling Domain Revealed by scRNA-Seq. Mol Ther. 2020 12 02; 28(12):2577-2592. PMID: 32755564.
    Citations: 4     Fields:    
  9. Shankar GM, Van Beaver LA, Choi BD, Hadzipasic M, Sivaganesan A, Karhade AV, Ferrone ML, Harris MB, Schoenfeld AJ, Sadow PM, Oh K, Schwab JH, Saylor PJ, Shin JH. Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes. Neurosurgery. 2020 Jun 10. PMID: 32521012.
    Citations: 1     Fields:    
  10. Choi BD. Editorial. A neurosurgery resident's response to COVID-19: anything but routine. J Neurosurg. 2020 Apr 17; 1-2. PMID: 32302994.
    Citations: 9     Fields:    
  11. Choi BD, Gerstner ER, Curry WT. A Common Rule for Resection of Glioblastoma in the Molecular Era. JAMA Oncol. 2020 04 01; 6(4):503-504. PMID: 32027348.
    Citations: 1     Fields:    Translation:Humans
  12. Choi BD, Yu X, Castano AP, Darr H, Henderson DB, Bouffard AA, Larson RC, Scarfò I, Bailey SR, Gerhard GM, Frigault MJ, Leick MB, Schmidts A, Sagert JG, Curry WT, Carter BS, Maus MV. CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma. J Immunother Cancer. 2019 11 14; 7(1):304. PMID: 31727131.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  13. Schmidts A, Ormhøj M, Choi BD, Taylor AO, Bouffard AA, Scarfò I, Larson RC, Frigault MJ, Gallagher K, Castano AP, Riley LS, Cabral ML, Boroughs AC, Velasco Cárdenas RM, Schamel W, Zhou J, Mackay S, Tai YT, Anderson KC, Maus MV. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma. Blood Adv. 2019 11 12; 3(21):3248-3260. PMID: 31698455.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  14. Bernstock JD, Vicario N, Rong L, Valdes PA, Choi BD, Chen JA, DiToro D, Osorio DS, Kachurak K, Gessler F, Johnston JM, Atkinson TP, Whitley RJ, Bag AK, Gillespie GY, Markert JM, Maric D, Friedman GK. A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition. Oncoimmunology. 2019; 8(12):e1678921. PMID: 31741780.
    Citations: 1     
  15. Ormhøj M, Scarfò I, Cabral ML, Bailey SR, Lorrey SJ, Bouffard AA, Castano AP, Larson RC, Riley LS, Schmidts A, Choi BD, Andersen RS, Cédile O, Nyvold CG, Christensen JH, Gjerstorff MF, Ditzel HJ, Weinstock DM, Barington T, Frigault MJ, Maus MV. Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19. Clin Cancer Res. 2019 12 01; 25(23):7046-7057. PMID: 31439577.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  16. Choi BD, Yu X, Castano AP, Bouffard AA, Schmidts A, Larson RC, Bailey SR, Boroughs AC, Frigault MJ, Leick MB, Scarfò I, Cetrulo CL, Demehri S, Nahed BV, Cahill DP, Wakimoto H, Curry WT, Carter BS, Maus MV. CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity. Nat Biotechnol. 2019 09; 37(9):1049-1058. PMID: 31332324.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  17. Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus MV. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 2019 09 12; 134(11):860-866. PMID: 31320380.
    Citations: 22     Fields:    Translation:HumansCells
  18. Choi BD, Lee DK, Yang JC, Ayinon CM, Lee CK, Maus D, Carter BS, Barker FG, Jones PS, Nahed BV, Cahill DP, See RB, Simon MV, Curry WT. Receptor tyrosine kinase gene amplification is predictive of intraoperative seizures during glioma resection with functional mapping. J Neurosurg. 2019 Mar 29; 132(4):1017-1023. PMID: 30925466.
    Citations: 1     Fields:    
  19. Boroughs AC, Larson RC, Choi BD, Bouffard AA, Riley LS, Schiferle E, Kulkarni AS, Cetrulo CL, Ting D, Blazar BR, Demehri S, Maus MV. Chimeric antigen receptor costimulation domains modulate human regulatory T cell function. JCI Insight. 2019 03 14; 5. PMID: 30869654.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  20. Richardson LG, Choi BD, Curry WT. (R)-2-hydroxyglutarate drives immune quiescence in the tumor microenvironment of IDH-mutant gliomas. Transl Cancer Res. 2019 Mar; 8(Suppl 2):S167-S170. PMID: 30956952.
    Citations: 2     
  21. Choi BD, Maus MV, June CH, Sampson JH. Immunotherapy for Glioblastoma: Adoptive T-cell Strategies. Clin Cancer Res. 2019 04 01; 25(7):2042-2048. PMID: 30446589.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  22. Suryadevara CM, Desai R, Farber SH, Choi BD, Swartz AM, Shen SH, Gedeon PC, Snyder DJ, Herndon JE, Healy P, Reap EA, Archer GE, Fecci PE, Sampson JH, Sanchez-Perez L. Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts. Clin Cancer Res. 2019 01 01; 25(1):358-368. PMID: 30425092.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  23. Choi BD, Shankar GM, Sivaganesan A, Van Beaver LA, Oh K, Shin JH. Implication of Biomarker Mutations for Predicting Survival in Patients With Metastatic Lung Cancer to the Spine. Spine (Phila Pa 1976). 2018 Nov 01; 43(21):E1274-E1280. PMID: 29652780.
    Citations: 2     Fields:    Translation:HumansCells
  24. Choi BD, Stapleton CJ, Lee CK, Williams Z. Spontaneous migration of retained intracranial bullet. Br J Neurosurg. 2021 Feb; 35(1):119. PMID: 29943668.
    Citations:    Fields:    
  25. Choi BD, Curry WT, Carter BS, Maus MV. Chimeric antigen receptor T-cell immunotherapy for glioblastoma: practical insights for neurosurgeons. Neurosurg Focus. 2018 06; 44(6):E13. PMID: 29852773.
    Citations: 6     Fields:    Translation:HumansCells
  26. Gedeon PC, Schaller TH, Chitneni SK, Choi BD, Kuan CT, Suryadevara CM, Snyder DJ, Schmittling RJ, Szafranski SE, Cui X, Healy PN, Herndon JE, McLendon RE, Keir ST, Archer GE, Reap EA, Sanchez-Perez L, Bigner DD, Sampson JH. A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clin Cancer Res. 2018 08 01; 24(15):3611-3631. PMID: 29703821.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  27. Suryadevara CM, Desai R, Abel ML, Riccione KA, Batich KA, Shen SH, Chongsathidkiet P, Gedeon PC, Elsamadicy AA, Snyder DJ, Herndon JE, Healy P, Archer GE, Choi BD, Fecci PE, Sampson JH, Sanchez-Perez L. Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma. Oncoimmunology. 2018; 7(6):e1434464. PMID: 29872570.
    Citations: 26     
  28. Zimering JH, Choi BD, Koch MJ, Dewitt JC, Stemmer-Rachamimov A, Shin JH. Sporadic NF2 Mosaic: Multiple spinal schwannomas presenting with severe, intractable pain following pregnancy. Interdiscip Neurosurg. 2017 Dec; 10:142-145. PMID: 29780700.
  29. Choi BD, Fehnel KP, Butler WE. Rare Giant Prevertebral Thoracic Myelomeningocele. World Neurosurg. 2018 Jan; 109:296-297. PMID: 29042329.
    Citations:    Fields:    Translation:Humans
  30. Choi BD, Curry WT. IDH mutational status and the immune system in gliomas: a tale of two tumors? Transl Cancer Res. 2017 Oct; 6(Suppl 7):S1253-S1256. PMID: 29104858.
    Citations: 6     
  31. Choi BD, O'Rourke DM, Maus MV. Engineering Chimeric Antigen Receptor T cells to Treat Glioblastoma. J Target Ther Cancer. 2017 Aug; 6(4):22-25. PMID: 29167820.
    Citations: 5     
  32. Shankar GM, Choi BD, Grannan BL, Oh K, Shin JH. Effect of Immunotherapy Status on Outcomes in Patients With Metastatic Melanoma to the Spine. Spine (Phila Pa 1976). 2017 Jun 15; 42(12):E721-E725. PMID: 27879568.
    Citations: 2     Fields:    Translation:Humans
  33. Suryadevara CM, Desai R, Farber SH, Gedeon PC, Swartz A, Snyder D, Herndon J, Healy P, Choi BD, Fecci PE, Sanchez-Perez L, Sampson JH. 369 Chimeric Antigen Receptors Deficient in Lck Signaling Require 4-1BB Costimulation to Expand in Vivo, Resist Regulatory T-Cell Suppression, and Treat Solid Tumors in Immune-Intact Hosts. Neurosurgery. 2016 Aug; 63 Suppl 1:209-10. PMID: 27399566.
  34. Saraswathula A, Reap EA, Choi BD, Schmittling RJ, Norberg PK, Sayour EJ, Herndon JE, Healy P, Congdon KL, Archer GE, Sanchez-Perez L, Sampson JH. Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. Cancer Immunol Immunother. 2016 Feb; 65(2):205-11. PMID: 26759007.
    Citations: 3     Fields:    Translation:HumansCells
  35. Choi BD, Fecci PE, Sampson JH. Editorial: Not everything that matters can be measured and not everything that can be measured matters. J Neurosurg. 2015 Sep; 123(3):543-4. PMID: 26115465.
    Citations:    Fields:    Translation:Humans
  36. Suryadevara CM, Gedeon PC, Sanchez-Perez L, Verla T, Alvarez-Breckenridge C, Choi BD, Fecci PE, Sampson JH. Are BiTEs the "missing link" in cancer therapy? Oncoimmunology. 2015 Jun; 4(6):e1008339. PMID: 26155413.
    Citations: 26     
  37. Alvarez-Breckenridge CA, Choi BD, Suryadevara CM, Chiocca EA. Potentiating oncolytic viral therapy through an understanding of the initial immune responses to oncolytic viral infection. Curr Opin Virol. 2015 Aug; 13:25-32. PMID: 25846988.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  38. Suryadevara CM, Verla T, Sanchez-Perez L, Reap EA, Choi BD, Fecci PE, Sampson JH. Immunotherapy for malignant glioma. Surg Neurol Int. 2015; 6(Suppl 1):S68-77. PMID: 25722935.
    Citations: 18     
  39. DeLong MR, Hughes DB, Tandon VJ, Choi BD, Zenn MR. Factors Influencing Fellowship Selection, Career Trajectory, and Academic Productivity among Plastic Surgeons. Plast Reconstr Surg. 2014 Oct; 134(4 Suppl 1):110-1. PMID: 25254828.
  40. DeLong MR, Hughes DB, Choi BD, Zenn MR. Reply: factors influencing fellowship selection, career trajectory, and academic productivity among plastic surgeons. Plast Reconstr Surg. 2014 Oct; 134(4):667e-668e. PMID: 25357070.
    Citations: 1     Fields:    Translation:Humans
  41. Sanchez-Perez L, Suryadevara CM, Choi BD, Reap EA, Sampson JH. Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy. Oncoimmunology. 2014; 3(7):e944054. PMID: 25610727.
    Citations: 7     
  42. Miao H, Choi BD, Suryadevara CM, Sanchez-Perez L, Yang S, De Leon G, Sayour EJ, McLendon R, Herndon JE, Healy P, Archer GE, Bigner DD, Johnson LA, Sampson JH. EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma. PLoS One. 2014; 9(4):e94281. PMID: 24722266.
    Citations: 43     Fields:    Translation:HumansAnimalsCells
  43. Choi BD, DeLong MR, Sampson JH. Response. J Neurosurg. 2014 Mar; 120(3):728-9. PMID: 24724172.
    Citations:    Fields:    Translation:Humans
  44. DeLong MR, Hughes DB, Tandon VJ, Choi BD, Zenn MR. Factors influencing fellowship selection, career trajectory, and academic productivity among plastic surgeons. Plast Reconstr Surg. 2014 Mar; 133(3):730-736. PMID: 24572862.
    Citations: 6     Fields:    Translation:Humans
  45. Choi BD, DeLong MR, DeLong DM, Friedman AH, Sampson JH. Impact of PhD training on scholarship in a neurosurgical career. J Neurosurg. 2014 Mar; 120(3):730-5. PMID: 24359004.
    Citations: 1     Fields:    Translation:Humans
  46. Sampson JH, Choi BD, Sanchez-Perez L, Suryadevara CM, Snyder DJ, Flores CT, Schmittling RJ, Nair SK, Reap EA, Norberg PK, Herndon JE, Kuan CT, Morgan RA, Rosenberg SA, Johnson LA. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss. Clin Cancer Res. 2014 Feb 15; 20(4):972-84. PMID: 24352643.
    Citations: 87     Fields:    Translation:HumansAnimalsCells
  47. Choi BD, Gedeon PC, Sanchez-Perez L, Bigner DD, Sampson JH. Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody. Oncoimmunology. 2013 Dec 01; 2(12):e26757. PMID: 24475376.
    Citations: 17     
  48. Choi BD, Suryadevara CM, Gedeon PC, Herndon JE, Sanchez-Perez L, Bigner DD, Sampson JH. Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. J Clin Neurosci. 2014 Jan; 21(1):189-90. PMID: 24054399.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  49. Choi BD, Gedeon PC, Herndon JE, Archer GE, Reap EA, Sanchez-Perez L, Mitchell DA, Bigner DD, Sampson JH. Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody. Cancer Immunol Res. 2013 Sep; 1(3):163. PMID: 24570975.
    Citations: 20     Fields:    Translation:HumansCells
  50. Choi BD, Hodges TR, Grant GA, Fuchs HE, Cummings TJ, Muh CR. Inflammatory pseudotumor of the lateral ventricle in a pediatric patient. Pediatr Neurosurg. 2012; 48(6):374-8. PMID: 23948719.
    Citations:    Fields:    Translation:Humans
  51. Gedeon PC, Choi BD, Hodges TR, Mitchell DA, Bigner DD, Sampson JH. An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma. Expert Rev Clin Pharmacol. 2013 Jul; 6(4):375-86. PMID: 23927666.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  52. Choi BD, Gedeon PC, Kuan CT, Sanchez-Perez L, Archer GE, Bigner DD, Sampson JH. Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis. J Immunol Methods. 2013 Sep 30; 395(1-2):14-20. PMID: 23806556.
    Citations: 3     Fields:    Translation:HumansCells
  53. Sanchez-Perez L, Choi BD, Reap EA, Sayour EJ, Norberg P, Schmittling RJ, Archer GE, Herndon JE, Mitchell DA, Heimberger AB, Bigner DD, Sampson JH. BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide. Cancer Immunol Immunother. 2013 Jun; 62(6):983-7. PMID: 23591978.
    Citations: 10     Fields:    Translation:Humans
  54. Hodges TR, Choi BD, Bigner DD, Yan H, Sampson JH. Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review. J Neurosurg. 2013 Jun; 118(6):1176-80. PMID: 23581583.
    Citations: 9     Fields:    Translation:Humans
  55. Choi BD, Pastan I, Bigner DD, Sampson JH. A novel bispecific antibody recruits T cells to eradicate tumors in the "immunologically privileged" central nervous system. Oncoimmunology. 2013 Apr 01; 2(4):e23639. PMID: 23734318.
    Citations: 10     
  56. Sanchez-Perez LA, Choi BD, Archer GE, Cui X, Flores C, Johnson LA, Schmittling RJ, Snyder D, Herndon JE, Bigner DD, Mitchell DA, Sampson JH. Myeloablative temozolomide enhances CD8? T-cell responses to vaccine and is required for efficacy against brain tumors in mice. PLoS One. 2013; 8(3):e59082. PMID: 23527092.
    Citations: 36     Fields:    Translation:AnimalsCells
  57. Gedeon PC, Choi BD, Sampson JH, Bigner DD. Rindopepimut: anti-EGFRvIII peptide vaccine, oncolytic. Drugs Future. 2013 Mar; 38(3):147-155. PMID: 25663738.
    Citations: 11     
  58. Choi BD, Kuan CT, Cai M, Archer GE, Mitchell DA, Gedeon PC, Sanchez-Perez L, Pastan I, Bigner DD, Sampson JH. Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):270-5. PMID: 23248284.
    Citations: 48     Fields:    Translation:AnimalsCells
  59. Mehta AI, Choi BD, Ajay D, Raghavan R, Brady M, Friedman AH, Pastan I, Bigner DD, Sampson JH. Convection enhanced delivery of macromolecules for brain tumors. Curr Drug Discov Technol. 2012 Dec; 9(4):305-10. PMID: 22339074.
    Citations: 14     Fields:    Translation:Humans
  60. Ajay D, Sanchez-Perez L, Choi BD, De Leon G, Sampson JH. Immunotherapy with tumor vaccines for the treatment of malignant gliomas. Curr Drug Discov Technol. 2012 Dec; 9(4):237-55. PMID: 22339070.
    Citations: 3     Fields:    Translation:Humans
  61. Choi BD, Fecci PE, Sampson JH. Regulatory T cells move in when gliomas say "I Do". Clin Cancer Res. 2012 Nov 15; 18(22):6086-8. PMID: 23052252.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  62. Reitman ZJ, Choi BD, Spasojevic I, Bigner DD, Sampson JH, Yan H. Enzyme redesign guided by cancer-derived IDH1 mutations. Nat Chem Biol. 2012 Nov; 8(11):887-9. PMID: 23001033.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  63. Choi BD, Mehta AI, Batich KA, Friedman AH, Sampson JH. The use of motor mapping to aid resection of eloquent gliomas. Neurosurg Clin N Am. 2012 Apr; 23(2):215-25, vii. PMID: 22440865.
    Citations: 1     Fields:    Translation:Humans
  64. Choi BD, Cai M, Bigner DD, Mehta AI, Kuan CT, Sampson JH. Bispecific antibodies engage T cells for antitumor immunotherapy. Expert Opin Biol Ther. 2011 Jul; 11(7):843-53. PMID: 21449821.
    Citations: 37     Fields:    Translation:HumansAnimalsCells
  65. Mehta AI, Choi BD, Raghavan R, Brady M, Friedman AH, Bigner DD, Pastan I, Sampson JH. Imaging of convection enhanced delivery of toxins in humans. Toxins (Basel). 2011 03; 3(3):201-6. PMID: 22069706.
    Citations: 13     Fields:    Translation:Humans
  66. Choi BD, Archer GE, Mitchell DA, Heimberger AB, McLendon RE, Bigner DD, Sampson JH. EGFRvIII-targeted vaccination therapy of malignant glioma. Brain Pathol. 2009 Oct; 19(4):713-23. PMID: 19744042.
    Citations: 49     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Choi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (173)
Co-Authors (59)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.